We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > lopinavir-ritonavir

News List

Triple antiviral drug combination shows early promise for treating COVID-19 in Phase II trial europeanpharmaceuticalreview
May 12, 2020
A Phase II clinical trial has shown that a two-week course of interferon beta-1b plus lopinavir-ritonavir and ribavirin, started within seven days of showing COVID-19 symptoms, is safe and effective.
New triple antiviral drugs combo shows promise against COVID-19: Study expresspharma
May 11, 2020
Treatment involving a combination of the drugs interferon beta-1b, plus antiviral therapy lopinavir-ritonavir and ribavirin, is better at reducing the viral load.
Positive results from initial lopinavir-ritonavir COVID-19 clinical trial europeanpharmaceuticalreview
April 08, 2020
Researchers found that the combination of lopinavir-ritonavir HIV antivirals led to rapid symptom improvement in COVID-19 patients.